Skip to content

Delcath Systems DCTH HEPZATO KIT — Product revenue

Other product segments

CHEMOSAT
$1.75M-0.8%

Similar metrics at other companies

Ardelyx logo
ARDXXPHOZAH — Total revenues
$23.3M-0.5%
Bristol-Myers Squibb logo
BMYZeposia — Total Revenues
$118M+10.3%
Organon logo
OGNZetia — Revenue
$87M+2.4%
Precigen logo
PGENPapzimeos — Total revenues
$21.59M
XER
XERSProduct revenue, net — Product revenue, net
$82.45M+42.6%
TransMedics Group, Inc. logo
TMDXProduct — Revenue
$107.97M+22.4%

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's hepzato kit — product revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's HEPZATO KIT — product revenue?
Delcath Systems (DCTH) reported HEPZATO KIT — product revenue of $23.25M in Q1 2026.
How has Delcath Systems's HEPZATO KIT — product revenue changed year-over-year?
Delcath Systems's HEPZATO KIT — product revenue increased by 29.0% year-over-year, from $18.02M to $23.25M.
What does HEPZATO KIT — product revenue mean?
This metric measures the total gross sales generated from the commercialization of a specific product or service line. It reflects the market adoption, pricing power, and commercial success of the offering within its target therapeutic area. Tracking this revenue is essential for evaluating the growth trajectory and financial contribution of a specific business segment.